According to Taisho Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 8.74%. At the end of 2022 the company had an Operating Margin of 8.04%.
Year | Operating Margin | Change |
---|---|---|
2022 | 8.04% | -1.95% |
2021 | 8.20% | -22.18% |
2020 | 10.54% | -57.28% |
2019 | 24.67% | 43.78% |
2018 | 17.16% | 14.42% |
2017 | 15.00% | 21.44% |
2016 | 12.35% | -10.67% |
2015 | 13.83% | -20.26% |
2014 | 17.34% | 14.37% |
2013 | 15.16% | -4.37% |
2012 | 15.85% | -19.65% |
2011 | 19.73% | 42.4% |
2010 | 13.86% | 32.56% |
2009 | 10.45% | -36.33% |
2008 | 16.42% | 37.01% |
2007 | 11.98% | -44.29% |
2006 | 21.51% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.